MetaVia Inc. — Director's Dealing 2018

Jan 30, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Gemphire Therapeutics Inc. (GEMP)
CIK: 0001638287
Period of Report: 2018-01-28

Reporting Person: MATHIESEN JEFFREY S (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-28	Employee Stock Option (right to buy)	$10.1	A	48000	Acquired	2028-01-27	Common Stock (48000)	Direct

Footnotes

F1: The option vests in a series of 48 successive equal monthly installments on the last day of each month, commencing on the grant date.